003020 立方制药
已收盘 08-14 15:00:00
资讯
新帖
简况
立方制药(003020)披露产品中选第12批国家药品集采,8月7日股价上涨5.13%
证券之星 · 08-07
立方制药(003020)披露产品中选第12批国家药品集采,8月7日股价上涨5.13%
股市必读:立方制药新发布《关于公司产品拟中选国家组织药品集中带量采购的公告》
证券之星 · 08-04
股市必读:立方制药新发布《关于公司产品拟中选国家组织药品集中带量采购的公告》
立方制药(003020.SZ):两款产品拟中选国家组织药品集中带量采购
智通财经 · 08-03
立方制药(003020.SZ):两款产品拟中选国家组织药品集中带量采购
立方制药旗下一款产品入选国家集中带量采购
美股速递 · 08-03
立方制药旗下一款产品入选国家集中带量采购
立方制药新注册《工时工序管理系统V1.0》项目的软件著作权
证券之星 · 07-31
立方制药新注册《工时工序管理系统V1.0》项目的软件著作权
异动快报:立方制药(003020)7月27日10点2分触及涨停板
证券之星 · 07-27
异动快报:立方制药(003020)7月27日10点2分触及涨停板
立方制药(003020.SZ)子公司聚乙烯醇滴眼液药品注册上市许可申请获受理
智通财经 · 07-21
立方制药(003020.SZ)子公司聚乙烯醇滴眼液药品注册上市许可申请获受理
异动快报:立方制药(003020)7月20日14点11分触及跌停板
证券之星 · 07-20
异动快报:立方制药(003020)7月20日14点11分触及跌停板
异动快报:立方制药(003020)7月17日10点58分触及跌停板
证券之星 · 07-17
异动快报:立方制药(003020)7月17日10点58分触及跌停板
异动快报:立方制药(003020)7月16日9点39分触及跌停板
证券之星 · 07-16
异动快报:立方制药(003020)7月16日9点39分触及跌停板
7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元
证券之星 · 07-15
7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元
7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-15
7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股
7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板
中金财经 · 07-13
7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板
异动快报:立方制药(003020)7月13日9点34分触及涨停板
证券之星 · 07-13
异动快报:立方制药(003020)7月13日9点34分触及涨停板
7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)
证券之星 · 07-10
7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)
7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-10
7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股
异动快报:立方制药(003020)7月9日10点18分触及涨停板
证券之星 · 07-09
异动快报:立方制药(003020)7月9日10点18分触及涨停板
7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股
证券之星 · 07-01
7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股
立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包
证券之星 · 06-02
立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包
股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%
证券之星 · 05-28
股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%
公司概况
公司名称:
合肥立方制药股份有限公司
所属行业:
批发业
上市日期:
2020-12-15
主营业务:
合肥立方制药股份有限公司的主营业务是药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。公司的主要产品是硝苯地平控释片、非洛地平缓释片、甲磺酸多沙唑嗪缓释片(国内首仿)、盐酸曲美他嗪缓释片、葛酮通络胶囊(独家品种)、盐酸羟考酮缓释片(10mg、40mg)、盐酸哌甲酯缓释片(国内首仿)、帕利哌酮缓释片、盐酸文拉法辛缓释片、益气和胃胶囊(独家品种)、虎地肠溶胶囊(独家品种)、亮菌口服溶液、金珍滴眼液(独家品种)、加替沙星滴眼液、吡嘧司特钾滴眼液、苄达赖氨酸滴眼液、马来酸噻吗洛尔滴眼液、盐酸丙美卡因滴眼液、丹皮酚软膏、克痤隐酮凝胶(独家品种)、复方土荆皮凝胶(独家品种)、尿素维E乳膏、坤宁颗粒、二甲双胍格列吡嗪片、伊曲康唑口服液(国内首仿)。公司两次荣获“中国医药工业最具投资价值企业”称号,连续八年入选“中国化学制药工业企业综合实力百强”,获国家高新技术企业、安徽省专精特新企业50强、安徽省科学技术奖一等奖、皖美品牌示范企业等荣誉,建有安徽省博士后科研工作站、安徽省认定企业技术中心、安徽省药物缓释工程技术中心,为安徽省医药行业协会理事长单位、合肥高新区上市企业协会会长单位,“立方”商标为中国驰名商标。
发行价格:
23.13
{"stockData":{"symbol":"003020","market":"SZ","secType":"STK","nameCN":"立方制药","latestPrice":18.65,"timestamp":1786690998000,"preClose":18.61,"halted":0,"volume":10128600,"delay":0,"changeRate":0.0021,"floatShares":169000000,"shares":227999999,"eps":0.7109,"marketStatus":"已收盘","change":0.04,"latestTime":"08-14 15:00:00","open":18.61,"high":18.94,"low":18.2,"amount":188000000,"amplitude":0.0398,"askPrice":18.66,"askSize":91,"bidPrice":18.65,"bidSize":148,"shortable":0,"etf":0,"ttmEps":0.7109,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":18.61,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":20.47,"lowLimit":16.75,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":228218618,"isCdr":false,"pbRate":2.3,"roa":"--","peRate":26.234351,"roe":"1.93%","epsLYR":0.87,"committee":0.613483,"marketValue":4256000000,"turnoverRate":0.0601,"status":0,"floatMarketCap":3143000000},"requestUrl":"/m/hq/s/003020/wiki","defaultTab":"wiki","newsList":[{"id":"2657641070","title":"立方制药(003020)披露产品中选第12批国家药品集采,8月7日股价上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641070","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657641070?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:09","pubTimestamp":1786111748,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,立方制药报收于18.43元,较前一交易日上涨5.13%,最新总市值为42.06亿元。近日,合肥立方制药股份有限公司披露公告,其产品甲磺酸多沙唑嗪缓释片和美阿沙坦钾片拟中选第12批国家组织药品集中带量采购,并于2026年8月6日正式公布中选结果。甲磺酸多沙唑嗪缓释片2025年度销售收入为10,340.95万元,占公司当年营业收入的6.66%;美阿沙坦钾片于2026年5月19日获批上市,尚未产生销售收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700040655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656305836","title":"股市必读:立方制药新发布《关于公司产品拟中选国家组织药品集中带量采购的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656305836","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656305836?lang=zh_cn&edition=full","pubTime":"2026-08-04 01:25","pubTimestamp":1785777912,"startTime":"0","endTime":"0","summary":"公司公告汇总关于公司产品拟中选国家组织药品集中带量采购的公告合肥立方制药股份有限公司参与第12批国家组织药品集中带量采购,甲磺酸多沙唑嗪缓释片和美阿沙坦钾片拟中选。甲磺酸多沙唑嗪缓释片2025年度销售收入为10,340.95万元,占公司营业收入6.66%;美阿沙坦钾片于2026年5月19日获批上市,尚未产生销售收入。采购周期至2029年12月31日,中选结果公示无异议后将签订合同。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656471913","title":"立方制药(003020.SZ):两款产品拟中选国家组织药品集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656471913","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656471913?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:06","pubTimestamp":1785729996,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 立方制药(003020.SZ)发布公告,近日,公司参与了国家组织药品集中带量采购(第12批)的申报。根据国家组织药品联合采购办公室于2026年7月31日发布的《第12批国家组织药品集中带量采购拟中选结果公示》显示,公司部分产品拟中选本次带量采购,相关产品为:甲磺酸多沙唑嗪缓释片、美阿沙坦钾片。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110638881","title":"立方制药旗下一款产品入选国家集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=1110638881","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110638881?lang=zh_cn&edition=full","pubTime":"2026-08-03 11:53","pubTimestamp":1785729195,"startTime":"0","endTime":"0","summary":"立方制药(Hefei Lifeon Pharmaceutical Co., Ltd.)透露,其两款产品有望被纳入国家集中带量采购计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800587","title":"立方制药新注册《工时工序管理系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655800587?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:15","pubTimestamp":1785435315,"startTime":"0","endTime":"0","summary":"证券之星消息,近日立方制药(003020)新注册了《工时工序管理系统V1.0》项目的软件著作权。今年以来立方制药新注册软件著作权1个。结合公司2025年年报财务数据,2025年公司在研发方面投入了1.11亿元,同比增20.7%。通过天眼查大数据分析,合肥立方制药股份有限公司共对外投资了11家企业,参与招投标项目6156次;财产线索方面有商标信息133条,专利信息94条,著作权信息3条;此外企业还拥有行政许可672个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654095563","title":"异动快报:立方制药(003020)7月27日10点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2654095563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654095563?lang=zh_cn&edition=full","pubTime":"2026-07-27 10:06","pubTimestamp":1785117963,"startTime":"0","endTime":"0","summary":"证券之星7月27日盘中消息,10点2分立方制药(003020)触及涨停板。其所属行业化学制药目前上涨。领涨股为哈三联。该股为脑科学,化学原料药,医药概念热股,当日脑科学概念上涨4.27%,化学原料药概念上涨3.65%,医药概念上涨3.38%。7月24日的资金流向数据方面,主力资金净流出725.69万元,占总成交额4.43%,游资资金净流入134.26万元,占总成交额0.82%,散户资金净流入591.42万元,占总成交额3.61%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700005166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653822350","title":"立方制药(003020.SZ)子公司聚乙烯醇滴眼液药品注册上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2653822350","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653822350?lang=zh_cn&edition=full","pubTime":"2026-07-21 11:45","pubTimestamp":1784605515,"startTime":"0","endTime":"0","summary":"智通财经APP讯,立方制药(003020.SZ)发布公告,近日,公司控股子公司合肥诺瑞特制药有限公司收到国家药品监督管理局下发的聚乙烯醇滴眼液药品注册上市许可申请的《受理通知书》。聚乙烯醇滴眼液可作为一种润滑剂预防或治疗眼部干涩、异物感、眼疲劳等刺激症状或改善眼部的干燥症状,适用于干眼症、视疲劳,以及配戴隐形眼镜、长时间用眼、环境干燥等因素引起的眼部干涩不适,已上市产品属于乙类非处方药(OTC)。本次申请属于仿制已在境内上市原研药品的药品,并同步申报OTC。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","IPOS","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652026729","title":"异动快报:立方制药(003020)7月20日14点11分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652026729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652026729?lang=zh_cn&edition=full","pubTime":"2026-07-20 14:15","pubTimestamp":1784528126,"startTime":"0","endTime":"0","summary":"证券之星7月20日盘中消息,14点11分立方制药(003020)触及跌停板。其所属行业化学制药目前下跌。领涨股为益方生物。该股为医药商业,医药,中药概念热股。7月17日的资金流向数据方面,主力资金净流入1974.23万元,占总成交额5.16%,游资资金净流出2481.52万元,占总成交额6.48%,散户资金净流入507.29万元,占总成交额1.32%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000016447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652927479","title":"异动快报:立方制药(003020)7月17日10点58分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652927479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652927479?lang=zh_cn&edition=full","pubTime":"2026-07-17 11:05","pubTimestamp":1784257524,"startTime":"0","endTime":"0","summary":"证券之星7月17日盘中消息,10点58分立方制药(003020)触及跌停板。其所属行业化学制药目前下跌。领涨股为哈药股份。该股为医药商业,中药,脑科学概念热股。7月16日的资金流向数据方面,主力资金净流出7281.19万元,占总成交额9.31%,游资资金净流入2146.74万元,占总成交额2.74%,散户资金净流入5134.45万元,占总成交额6.56%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700015454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497569","title":"异动快报:立方制药(003020)7月16日9点39分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651497569?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:41","pubTimestamp":1784166075,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息,9点39分立方制药(003020)触及跌停板。其所属行业化学制药目前下跌。领涨股为海创药业。该股为医药商业,医药,中药概念热股。7月15日的资金流向数据方面,主力资金净流入369.37万元,占总成交额0.38%,游资资金净流入1588.86万元,占总成交额1.64%,散户资金净流出1958.23万元,占总成交额2.02%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600008199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745988","title":"7月15日立方制药(003020)龙虎榜数据:北向资金净买入352.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651745988?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:28","pubTimestamp":1784107690,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月15日公布的交易公开信息显示,立方制药因日振幅值达到15%的前5只证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月15日收盘,立方制药报收于21.91元,上涨5.34%,换手率27.48%,成交量46.31万手,成交额9.71亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净买入352.17万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453718","title":"7月15日立方制药涨5.34%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651453718?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:32","pubTimestamp":1784104359,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日立方制药涨5.34%,收盘报21.91元,换手率27.48%,成交量46.31万手,成交额9.71亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651990711","title":"7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651990711","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651990711?lang=zh_cn&edition=full","pubTime":"2026-07-13 15:32","pubTimestamp":1783927926,"startTime":"0","endTime":"0","summary":"7月13日沪深两市涨停分析:国华退、立方制药、贵绳股份、亚联机械3连板 分时图\r\n\r\n 沪指低开低走跌超2%、创业板指跌逾3%,算力硬件概念持续走弱,全市场逾百股跌停。国华退、立方制药、贵绳股份、亚联机械3连板,一图看懂>>","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/13/20260713686105.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/13/20260713686105.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260713/32305671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["399300","001395","003020","BK0250","BK0251","600992","159982","BK0256","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162528","title":"异动快报:立方制药(003020)7月13日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651162528?lang=zh_cn&edition=full","pubTime":"2026-07-13 09:41","pubTimestamp":1783906880,"startTime":"0","endTime":"0","summary":"证券之星7月13日盘中消息,9点34分立方制药(003020)触及涨停板。其所属行业化学制药目前下跌。领涨股为立方制药。该股为中药,医药商业,医药概念热股,当日中药概念上涨0.46%,医药商业概念上涨0.16%。7月10日的资金流向数据方面,主力资金净流入4638.66万元,占总成交额14.3%,游资资金净流出722.44万元,占总成交额2.23%,散户资金净流出3916.22万元,占总成交额12.07%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300004301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650186212","title":"7月10日立方制药(003020)龙虎榜数据:机构净买入1663.54万元(3日),北向资金净卖出390.53万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650186212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650186212?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:28","pubTimestamp":1783675681,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月10日公布的交易公开信息显示,立方制药因连续三个交易日内,涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月10日收盘,立方制药报收于18.74元,上涨9.98%,已连续涨停2天,换手率10.58%,成交量17.84万手,成交额3.24亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入1663.54万元,北向资金合计净卖出390.53万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650424183","title":"7月10日立方制药涨9.98%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650424183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650424183?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:32","pubTimestamp":1783672338,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日立方制药涨9.98%,收盘报18.74元,换手率10.58%,成交量17.84万手,成交额3.24亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650910128","title":"异动快报:立方制药(003020)7月9日10点18分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2650910128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650910128?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:25","pubTimestamp":1783563923,"startTime":"0","endTime":"0","summary":"证券之星7月9日盘中消息,10点18分立方制药(003020)触及涨停板。其所属行业化学制药目前上涨。领涨股为立方制药。该股为脑科学,眼科,医药概念热股,当日脑科学概念上涨0.55%,眼科概念上涨0.16%。7月8日的资金流向数据方面,主力资金净流出335.74万元,占总成交额5.44%,游资资金净流入384.3万元,占总成交额6.23%,散户资金净流出48.56万元,占总成交额0.79%。近5日资金流向一览见下表:立方制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900012259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516601","title":"7月1日立方制药涨9.12%,兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648516601?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:50","pubTimestamp":1782895801,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日立方制药涨9.12%,收盘报16.16元,换手率4.61%,成交量7.77万手,成交额1.23亿元。重仓立方制药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640919992","title":"立方制药最新公告:举办股东感恩回馈活动提供专属优惠价产品礼包","url":"https://stock-news.laohu8.com/highlight/detail?id=2640919992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640919992?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:23","pubTimestamp":1780392197,"startTime":"0","endTime":"0","summary":"立方制药(003020.SZ)公告称,公司为答谢股东支持,将举办“股东感恩回馈活动”。2026年5月28日收市后登记在册的全体股东,可在公告发布之日起至2026年6月25日期间,以专属优惠价购买指定产品礼包1份,礼包包含丹皮酚软膏5盒,数量上限为15000份,先到先得。本次活动不属于利润分配,不会对公司经营产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200033085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638751638","title":"股市必读:立方制药(003020)今年截至5月27日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638751638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638751638?lang=zh_cn&edition=full","pubTime":"2026-05-28 02:55","pubTimestamp":1779908110,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,立方制药报收于19.81元,下跌2.17%,换手率1.55%,成交量2.18万手,成交额4305.31万元。交易信息汇总股价提醒5月27日立方制药收盘报19.81元,跌2.17%,当日成交218.06万元。该股已连续3日下跌,当年累计跌幅20.23%。前10个交易日主力资金累计净流出3082.11万元,期间股价累计下跌9.59%。资金流向5月27日主力资金净流出307.73万元;游资资金净流入412.5万元;散户资金净流出104.78万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786911350348,"stockEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.1488},{"period":"3month","weight":0.0454},{"period":"6month","weight":-0.1174},{"period":"1year","weight":-0.1906},{"period":"ytd","weight":-0.1218}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"合肥立方制药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"16639人(较上一季度减少89.24%)","perCapita":"10129股","listingDate":"2020-12-15","address":"安徽省合肥市蜀山区长江西路669号立方厂区","registeredCapital":"22821万元","survey":" 合肥立方制药股份有限公司的主营业务是药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。公司的主要产品是硝苯地平控释片、非洛地平缓释片、甲磺酸多沙唑嗪缓释片(国内首仿)、盐酸曲美他嗪缓释片、葛酮通络胶囊(独家品种)、盐酸羟考酮缓释片(10mg、40mg)、盐酸哌甲酯缓释片(国内首仿)、帕利哌酮缓释片、盐酸文拉法辛缓释片、益气和胃胶囊(独家品种)、虎地肠溶胶囊(独家品种)、亮菌口服溶液、金珍滴眼液(独家品种)、加替沙星滴眼液、吡嘧司特钾滴眼液、苄达赖氨酸滴眼液、马来酸噻吗洛尔滴眼液、盐酸丙美卡因滴眼液、丹皮酚软膏、克痤隐酮凝胶(独家品种)、复方土荆皮凝胶(独家品种)、尿素维E乳膏、坤宁颗粒、二甲双胍格列吡嗪片、伊曲康唑口服液(国内首仿)。公司两次荣获“中国医药工业最具投资价值企业”称号,连续八年入选“中国化学制药工业企业综合实力百强”,获国家高新技术企业、安徽省专精特新企业50强、安徽省科学技术奖一等奖、皖美品牌示范企业等荣誉,建有安徽省博士后科研工作站、安徽省认定企业技术中心、安徽省药物缓释工程技术中心,为安徽省医药行业协会理事长单位、合肥高新区上市企业协会会长单位,“立方”商标为中国驰名商标。","listedPrice":23.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"立方制药,003020,立方制药股票,立方制药股票老虎,立方制药股票老虎国际,立方制药行情,立方制药股票行情,立方制药股价,立方制药股市,立方制药股票价格,立方制药股票交易,立方制药股票购买,立方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}